Analytical Data
-
Gene name
ABHD13
- Application
-
Alternative Names
ABHD13; C13orf6; Protein ABHD13; Alpha/beta hydrolase domain-containing Protein 13
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7L211
-
Expression Region
1-337aa
-
AA Sequence
MEKSWMLWNFVERWLIALASWSWALCRISLLPLIVTFHLYGGIILLLLIFISIAGILYKFQDVLLYFPEQPSSSRLYVPMPTGIPHENIFIRTKDGIRLNLILIRYTGDNSPYSPTIIYFHGNAGNIGHRLPNALLMLVNLKVNLLLVDYRGYGKSEGEASEEGLYLDSEAVLDYVMTRPDLDKTKIFLFGRSLGGAVAIHLASENSHRISAIMVENTFLSIPHMASTLFSFFPMRYLPLWCYKNKFLSYRKISQCRMPSLFISGLSDQLIPPVMMKQLYELSPSRTKRLAIFPDGTHNDTWQCQGYFTALEQFIKEVVKSHSPEEMAKTSSNVTII
-
Molecular Weight
38.5 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ABHD13 (Abhydrolase Domain Containing 13) is a member of the serine hydrolase family, playing a crucial role in the regulation of lipid metabolism and cellular signaling pathways. It is believed to be involved in the hydrolysis of bioactive lipids, thereby influencing numerous physiological processes such as inflammation, neuroprotection, and energy homeostasis. Recent studies have highlighted its potential implications in various pathological conditions, including obesity, diabetes, and neurodegenerative diseases. The functional characterization of ABHD13, particularly through the production of recombinant proteins, has gained significant attention as it allows for a deeper understanding of its enzymatic activity, substrate specificity, and regulatory mechanisms. By utilizing recombinant DNA technology, researchers can express and purify ABHD13 in a controlled environment, facilitating kinetic studies and the exploration of its interactions with small molecules, making it a promising target for drug discovery and therapeutic intervention. Understanding the structure-function relationship of ABHD13 through recombinant protein expression may pave the way for novel approaches in treating diseases linked to lipid dysregulation. Thus, the study of ABHD13 recombinant proteins not only enhances our basic scientific knowledge but also holds potential for translational applications in medicine.
